LIM Chien Wei John
Affiliation
- NUS Saw Swee Hock School of Public Health (Joint)
- Executive Director, Centre of Regulatory Excellence, Duke-NUS Graduate Medical School (Primary)
- Senior Advisor, Ministry of Health, Singapore
- Chairman, Singapore Clinical Research Institute
Research Areas
- Health Regulation/Regulatory Science
Teaching Areas
- Health Regulation/Regulatory Science
- Health Administration
Academic/Professional Qualifications
- MBBS (Singapore)
- M Sc (Public Health) (Singapore)
- SM (Health Policy & Management) (Harvard)
- AM (Singapore)
Awards
- Tye Cho Yook Gold Medal
Career History and Administrative Leadership
- Chief Executive Officer, Health Sciences Authority
- Administrator, Singapore Blood Transfusion Service
- Special Assistant to PS/DMS, Ministry of Health
- Deputy Director, Institute of Mental Health
- Deputy Director of Medical Services (Industry & Research Matters), Ministry of Health
- Director, Human Resource, Ministry of Health
- Director, Higher Education & Public Affairs, Ministry of Education
- Director, Centre for Drug Administration, Health Sciences Authority
- Deputy Chief Executive Officer, Health Sciences Authority
Selected Publications
- Lim JCW, Chan CL, Green A. Global Challenges in Regulatory Capacity and Capability Building: Extrapolating Lessons Learned From the HSA. Clinical Pharmacology & Therapeutics. 2018, Advance on line publication, November 20, 2018. DOI: 10.1002/cpt.1253
- Roth L, et al. Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems. Globalization and Health, Open 2018, 14:102. DOI:10.1186/s12992-018-0421-2.
- Chong SSF, Lim JCW, Tominaga T. Developing key performance indicators to measure the progress of regional regulatory convergence and cooperation in Asia-Pacific Economic Co-operation (APEC). American Association of Pharmaceutical Scientists (AAPS) Open 2018, 4:4. DOI:10.1186/s41120-018-0024-2.
- Lim JCW. Strengthening Health Products Regulatory Systems to Enhance Access to Quality Health Products in the Asia-Pacific. Therapeutic Innovation & Regulatory Science 2018, Vol. 52(6) 751-754. First published April 12, 2018. DOI: 10.1177/2168479018769285.
- Baird LG, et al. Accelerated access to innovative medicines for patients in need.Nature, Clinical Pharmacology & Therapeutics. 2014 Nov; 96(5):559-71. DOI: 10.1038/clpt.2014.145. First published July 9, 2014.
- Eichler HG, et al. Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval. Nature, Clinical Pharmacology & Therapeutics. 2012; 91(3):426–437. DOI: 10.1038/clpt.2011.345